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Abstract
Background: Timely switch from intravenous (iv) antibiotics to oral therapy is a key component of antimicrobial
stewardship programs in order to improve patient safety, promote early discharge and reduce costs. We have
introduced a time-efficient and easily implementable intervention that relies on a computerized trigger tool, which
identifies patients who are candidates for an iv to oral antibiotic switch.
Methods: The intervention was introduced on all internal medicine wards in a teaching hospital. Patients were
automatically identified by an electronic trigger tool when parenteral antibiotics were used for >48 h and clinical or
pharmacological data did not preclude switch therapy. A weekly educational session was introduced to alert the
physicians on the intervention wards. The intervention wards were compared with control wards, which included
all other hospital wards. An interrupted time-series analysis was performed to compare the pre-intervention
period with the post-intervention period using ‘% of i.v. prescriptions >72 h’ and ‘median duration of iv therapy
per prescription’ as outcomes. We performed a detailed prospective evaluation on a subset of 244 prescriptions
to evaluate the efficacy and appropriateness of the intervention.
Results: The number of intravenous prescriptions longer than 72 h was reduced by 19% in the intervention
group (n = 1519) (p < 0.01) and the median duration of iv antibiotics was reduced with 0.8 days (p = <0.05).
Compared to the control group (n = 4366) the intervention was responsible for an additional decrease of 13%
(p < 0.05) in prolonged prescriptions.
The detailed prospective evaluation of a subgroup of patients showed that adherence to the electronic reminder
was 72%.
Conclusions: An electronic trigger tool combined with a weekly educational session was effective in reducing
the duration of intravenous antimicrobial therapy.
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Background
Most patients with an infection that requires inpatient
treatment initially receive empirical intravenous (iv) anti-
microbial therapy. When the patient clinically improves
within 48 h and results from microbiology cultures and
other tests become available these iv antibiotics may be
switched to oral therapy, with the exception of certain
clinical conditions that necessitate prolonged iv treatment
(e.g. Staphylococcus aureus bacteremia, endocarditis, men-
ingitis). Previous studies have shown that a timely switch
from intravenous to oral therapy is safe and reduces risk
of complications related to intravenous treatment, health-
care costs and duration of hospitalization [1–6].
A Dutch study found that for patients with community-
acquired pneumonia, a switch to oral antibiotics was
possible in 46% of the patients on day 3 of treatment, but
was not performed in 40% of eligible switch opportunities
[7]. Barriers that preclude switching include misconcep-
tions, practical considerations and organizational factors
[7, 8]. Different approaches have been deployed to incorp-
orate switch therapy into daily practice. However, the
major conversion programmes evaluated in the literature
were labour intensive interventions [3, 4] and not aimed
at solving the barriers to timely switching therapy from iv
to oral [5]. Previous research showed that introducing
switch therapy into daily practice by a computerized trig-
ger tool was effective in promoting iv to oral switch ther-
apy [9, 10]. However, these reminders were produced with
low specificity, were only performed for a limited number
of antibiotics or had a low adherence rate.
The goal of this study was to evaluate the effect of a
combined intervention targeting different barriers that
preclude switching. The first intervention, a computer-
ized reminder, was chosen to target both practical and
organisational factors, while continuous education and
feedback on iv-oral switch practice and promoting the
use of a so called ‘switch card’ aimed to improve miscon-
ceptions about switching. The computerized reminder
relies on an electronic trigger tool, which identifies pa-
tients who are candidates for antibiotic switch therapy.
With this combined intervention we aimed to improve
the rate of safe iv to oral antibiotic switch on internal
medicine wards.
Methods
This controlled intervention study was performed at the
Canisius-Wilhemina Hospital, Nijmegen, the Netherlands,
a 455-bed non-academic teaching hospital. The study was
performed during a 26-month period. The pre-intervention
period was defined as the first 13 months of the study
period and the post-intervention period was defined as the
last 13 months of the study period. The intervention was
carried out at the internal medicine wards. The control
wards included all other hospital wards.
Intervention
Computerised reminders
The multidisciplinary Antimicrobial Stewardship team
(AST) (comprised of an infectious disease specialist,
microbiologist and clinical pharmacist) created an auto-
matic warning system that identifies candidates who are eli-
gible for iv-oral switch therapy. The tool was based on the
Dutch National Antibiotic Switch guidelines [3] and was
developed in Crystal Reports® using data from the hospital
pharmacy database and the clinical chemistry department.
Patients were identified as eligible for iv-oral switch
therapy when antibiotic treatment had been prescribed
48 to 72 h previously. To alert the physician of the pos-
sibility of iv-oral switch an automated reminder was sent
on day 3 of the treatment. This trigger tool automatically
checked whether the following clinical or pharmaco-
logical conditions precluded switch therapy: (i) increase
in CRP during iv treatment; (ii) neutrophils <0,5*109/ml;
(iii) leukocytes <1*109/ml; (iv) usage of parenteral medi-
cation only or total parenteral nutrition, as an inability
for oral intake predictor; (v) specific or high dose antibiotic
suggesting severe infection (e.g. endocarditis, meningitis)
(Additional file 1: Appendix 1). Patients meeting one or
more of these criteria were not selected for switch therapy.
If a single patient received more than one antibiotic, each
single prescription (given for more than 48 h) was checked
by the trigger tool to determine eligibility for iv-oral switch.
Every morning, for each eligible patient, a written notice
was automatically generated and sent out to the depart-
ment secretary. This form contained identifying data of the
patient, the antibiotic(s) that were eligible to be switched,
and possible oral options or alternatives for these anti-
biotics. The form was presented to the attending phys-
ician during ward rounds by the department secretary.
The decision whether to switch or not was made by the
physician, based on the clinical situation of the patient.
For each patient the physician was asked to fill in a form
on which considerations concerning the switch were listed
(ability to switch, impeding reasons). Reasons precluding
iv-oral switch were categorized as ‘clinical instability’, no
oral intake possible, severe infection (e.g. Staphylococcus
aureus bacteremia, meningitis, endocarditis) or resistant
micro-organisms for which no oral therapy is available.
A second reminder was sent when the iv medication
order was started 96 to 120 h before and no oral switch had
yet been performed, based on the same algorithm as men-
tioned earlier. To prevent alert fatigue a maximum of two
reminders per medication order per patient was chosen.
Due to organizational factors no switch forms were
distributed during the weekend.
Educational program
The start of the intervention was preceded by an educa-
tional program. Pocket cards with the switch protocol
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were presented to each physician. The hospital protocol
(Additional file 2: Appendix 2) recommends to choose
an oral antibiotic based on culture results. When no oral
formulation of the iv antibiotic eligible for switch is
available and culture results are negative, an oral antibiotic
covering a similar spectrum as the empirically started iv
antibiotic is recommended (e.g. ceftriaxon should be
switched to oral amoxicillin/clavulanic acid).
To optimize adherence, direct feedback and education
was given to the physicians working on the intervention
wards regarding the returned switch forms in a weekly
short meeting.
During this 15-min meeting (called “Switch of the
week”) one or more of the completed switch forms were
selected by an infectious disease specialist (T.S.) and the
content was presented to the physicians. Both appropri-
ate and inappropriate decisions of the physicians were
discussed and feedback was given on the decisions
made.
Prospective observational study to assess the
effectiveness of the intervention
To determine the effectiveness of the intervention in
promoting iv-oral switch therapy, data of all iv antibiotic
prescriptions was collected from the hospital pharmacy
database for the whole study period. The intervention
group was represented by patients from the internal
medicine wards, while the control group was represented
by patients in the same hospital during the same period
from all other wards. The intervention was carried out at
the internal medicine wards during the last 13 months of
the study period. The percentage of intravenous prescrip-
tions that exceed 72 h (% > 72 h) and median treatment
duration in days of intravenous therapy on the interven-
tion wards were calculated and compared to the control
period and the control wards.
Detailed prospective evaluation of a subset of
prescriptions to assess appropriateness
During the first 4 months of the intervention period,
antibiotic prescriptions selected by the trigger tool were
included in a detailed analysis to evaluate the efficacy
and appropriateness of the intervention. The following
patient data were collected to categorize the switch: pa-
tient’s age and gender, source of infection, time of
hospitalization, antimicrobial treatment, starting date,
dose, body temperature, blood leukocyte count, blood
neutrophil count, culture results and reasons which im-
peded the switch, based on the returned switch-forms.
The appropriateness of the iv to oral switch was evalu-
ated by an infectious disease specialist (TS). Options to
categorize the conversion were: ‘appropriate switch’,
‘inappropriate switch’, ‘appropriate continuation of iv
therapy’ and ‘inappropriate continuation of iv therapy.
Categorization was based on the following switch criteria:
no indication for prolonged iv antibiotic treatment (e.g.
Staphylococcus aureus bacteremia, endocarditis, menin-
gitis), improving vital signs, susceptible micro-organism
(if cultured) for oral antibiotics, and the presence of a
functional tractus digestivus. A patient who fulfilled
these 4 switch criteria and who was switched to oral
antibiotic therapy was categorized as an appropriate
switch (Additional file 2: Appendix 2 – Table S3).
Endpoints
The primary endpoints were the change in percentage of
iv treatment exceeding >72 h for all patients in both
the intervention group and control group between the
pre- and post-intervention period and the percentage
of patients appropriately switched to oral therapy on
day 3 of treatment. Secondary outcome was the change
in median treatment duration.
Statistics
All data was analyzed using the IBM SPSS20 software
package. We performed an interrupted time series analysis
(ITSA), for which we used segmented linear regression to
assess the significance of changes in level and slope of the
regression lines before and after the introduction of the
intervention for both the intervention and control groups
[11, 12]. This methodology evaluates data collected at
multiple time points before and after an intervention to
detect whether the intervention had a greater effect than
the expected secular trend. An abrupt intervention effect
constitutes a change in the level of the outcome directly
after the intervention is implemented. The slope repre-
sents a gradual change in the outcome parameter during
the segment [12]. We divided the dataset into monthly pe-
riods (of which there were 26; 13 periods before the inter-
vention started and 13 periods after the intervention
started). The analysis was performed for the outcomes
percentage of iv treatment >72 h, and median treatment
duration in both the intervention and control group. We
used a p-value of <0.05 as a threshold for all statistical
tests.
Adherence to the intervention was determined by div-
iding the prescriptions that were appropriately switched
(numerator) by the total amount of prescriptions eligible
for switch (denominator).
Ethics statement
As iv to oral antibiotic switch therapy is proven to be
safe and effective and is an essential element of many
antimicrobial stewardship programs we considered timely
switch as a standard of care, and our study is an evaluation
of a new method to promote this standard of care. Patient
data were collected anonymously. This study does not
fall within the remit of the Medical Research involving
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Human Subjects Act (WMO). Therefore the study can
be carried out in the Netherlands without an approval
by an accredited research ethics committee and without
explicit informed consent of the participants.
Results
Baseline characteristics
During the whole study period, 1519 patients on the
intervention wards and 4366 patients on the control wards
received intravenous antibiotics (Table 1). At baseline, on
the intervention wards 50.5% of prescriptions were given
for >72 h versus 49.8% on the control wards.
Prospective observational study to assess the effectiveness
of the intervention
Using interrupted time-series analysis, we compared the
percentage of iv antibiotic prescriptions >72 h in the
pre-intervention and post-intervention periods. There was
a significant decrease (reduction 19.3%, p < 0.001; Table 2,
Fig. 1) in the intervention group. We observed a significant
but smaller decrease in the control group as well (reduction
6.1%, p < 0.05; Table 2, Fig. 1). The difference between the
intervention and control group showed a significant add-
itional reduction of intravenous antibiotic usage of 13.2%
(p = 0.014) in favour of the intervention group.
During the post-intervention period, a non-significant
increase in % of prescriptions >72 h was observed in the
intervention-group (solid line in the white area, slope of
+0.48% / month, p = 0.43; Fig. 1) and a non-significant
decrease in the control group (dashed line in the white
area, slope of −0.26% /month, p = 0.46; Fig. 1), with no
significant difference between these groups.
Median duration of antibiotic usage on the intervention
wards was decreased by 0.8 day (4.0 to 3.2, p = 0.015)
(Table 2) after the intervention was introduced. There was
no significant decrease observed on the control wards or
between the intervention and control wards.
Detailed prospective evaluation of a subset of
prescriptions to assess appropriateness
During a 4-month period there were 244 unique anti-
biotic medication orders for which the intervention was
activated, 21 prescriptions were excluded, since these
patients left the hospital on the day of the possible iv-
oral switch. This resulted in 223 medication orders for a
detailed analysis (Fig. 2).
Of all medication orders, 116 were eligible for switch.
Of these, 84 were switched correctly (72%) and 32 (28%)
were incorrectly not switched. A total of 78 orders were
not eligible for switch. For 29 orders there was no evalu-
ation possible, either because the switch order was gen-
erated in the weekend or there was no form filled in.
Most of the patients with medication orders that were
candidates for conversion had pneumonia (24.7%). The
mean age was 71 years and most patients were female
(53%). Table 3 shows data about the infections treated,
and antibiotics prescribed during this phase of the study.
The antibiotic agent that was most often eligible for
switch was cefotaxime (27.5%).
During the detailed prospective evaluation, the digital
switch forms were generated at two points in time. In
case the first form did not result in a switch, a second
form was generated from 96 to 120 h after therapy initi-
ation. This resulted in 56 switch forms generated of
which 20 lead to a correct switch and no incorrect
switches, 31 were not eligible for iv-oral switch and 5
were indicated as incorrectly not switched (Fig. 2).
This detailed analysis showed that no patients were in-
appropriately switched.
Discussion
A computerized intervention in combination with an
educational and feedback program, safely reduces the
percentage of prolonged intravenous antibiotic use in
hospital wards with 19%.
Many studies have demonstrated that iv-oral switch
therapy is associated with a reduced length of iv therapy
and low clinical failure rate [6]. In most studies an inves-
tigator identified cases eligible for switch by manual data
extraction. This is time consuming and has limited feasi-
bility in daily practice.
In this study, a simple automated trigger tool in our
clinical pharmacy database, selected patients eligible for
switch. An automated reminder was printed and sent to
the ward prompting the physician to perform an iv-oral
switch.
Table 1 Baseline characteristics of patients on the intervention wards and controls wards during the pre-intervention and
post-intervention periods
Characteristic Intervention wards Control wards
Pre-intervention period Post-intervention period Pre-intervention period Post-intervention period
Patients 771 748 2154 2212
Hospital admissions 880 835 2458 2478
Medication orders (iv antibiotics) 1781 1534 4769 4294
Mean age [range] 68.3 [16–101] 68.4 [17–101] 54.8 [1–100] 54.1 [0–98]
Female (%) 405 (53%) 371 (50%) 1029 (48%) 1073 (49%)
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Table 2 Change in percentage of iv antibiotic prescriptions >72 h and median antibiotic duration (days) during the pre-intervention
and post-intervention period and comparison between the intervention and control group using interrupted time series analysis
Slope during the pre-
intervention period (SE)
P Change in level after
interventiona (SE)
P Slope during the post-
intervention periodb (SE)
P
Percentage of iv antibiotic prescriptions >72 h (%)
Intervention group −0.03 (0.42) 0.94 −19.30 (4.41) <0.01 0.48 (0.59) 0.43
Control group −0.36 (0.25) 0.16 −6.12 (2.61) <0.05 −0.26 (0.35) 0.46
Difference between intervention
and control group
0.33 (0.48) 0.50 −13.17 (5.13) <0.05 0.74 (0.68) 0.29
Median duration of iv antibiotics (days)
Intervention group −0.02 (0.03) 0.49 −0.77 (0.29) 0.015 0.02 (0.04) 0.63
Control group −0.38 (0.03) 0.16 −0.15 (0.28) 0.59 0.04 (0.04) 0.32
Difference between intervention
and control group
0.02 (0.04) 0.62 0.62 (0.41) 0.14 −0.02 (0.05) 0.72
aMeasures the immediate impact of the intervention
bMeasures the long-term impact over time of the intervention
Fig. 1 Interrupted time series analysis of percentage of iv antimicrobial prescriptions >72 h. The grey area in the chart represents the pre-intervention
period, the white area the post-intervention period. The squares represent the control group, where the triangles represent the intervention group. A
trend line has been drawn through the data points for each group during the pre- and post-intervention period. The time series analysis demonstrated
a significant decrease in the percentage of antimicrobial prescriptions in the intervention group (solid lines and solid double arrow, reduction 19.3%;
p < 0.01) and in the control group (dashed lines and dashed double arrow, reduction 6.1%; p < 0.05), with an additional reduction of 13.2% (p < 0.05)
in favour of the intervention group
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By automating the intervention, we were able to sys-
tematically reduce workload, which was a problem in
many other studies [13]. In addition, we gave direct feed-
back to the participating physicians improving adherence
to the national iv-oral switch guideline. This resulted in
a high switch-rate of 72%.
The use of a computerized intervention has been in-
vestigated in a limited number of studies. Fisher et al.
developed computerized interventions which automatic-
ally sent reminders to the physician, when an iv-oral
switch was possible. Of the iv orders 21.6% were re-
placed by an oral agent, and 14% of the selected orders
were discontinued [10]. However, this intervention was
initiated on only 5 different categorized target drugs and
adherence was low. Another study showed a decrease of
iv use of levofloxacin and ciprofloxacin when displaying
electronic alerts [9].
Beeler et al. [14] performed a prospective, controlled
trial using an electronic reminder to stimulate iv-oral
Fig. 2 Prospective evaluation of a subset of prescriptions. *no switch form returned or switch form generated during weekend days
Table 3 Detailed prospective analysis; indications and
antibiotics prescribed for 244 analysed switch forms
Indication Antibiotic
Pneumonia 24.7% cefotaxim 27.5%
Sepsis 20.4% ciprofloxacin 19.0%
Pyelonephritis/urosepsis 18.6% amoxicillin 16.2%
Abdominal infection 17.6% metronidazole 15.0%
Skin and soft tissue infection 11.5% cefazolin 12.1%
Unknown indication 2.5% penicillin 4.5%
Gastro-enteritis 2.5% clindamycin 4.0%
Bone and joint infection 1.1% fluconazole 0.8%
Other 1.1% ceftriaxone 0.4%
flucloxacillin 0.4%
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switch. Their study resulted in a decrease of total iv dur-
ation of 17.5% in the intervention group, and a switch-rate
of 26.6%. Unfortunately, they did not report on the
amount of patients who were not eligible for switch, which
could explain the difference with the adherence rate in
our own study.
Our study has several strengths. First, we used a large
patient population and physician response to the switch
reminder was high (72%). The advantage of our switch
intervention lies in the possibilities of automatically
identifying patients eligible for switch and alerting the
physician. Besides the distribution of the switch-forms
by the department secretary, no man-power is required
for the continuous operation of the trigger tool, further-
more the educational program only takes 15-min a week.
This enables antimicrobial stewardship teams to focus
on other stewardship activities. The implementation of
more sophisticated electronic health record systems
(EHRS), which provide electronic alerts, could contrib-
ute to an additional reduction of workload [14, 15].
A recent survey conducted in France showed that hu-
man resources needed to implement AST activities were
estimated at 3.6 full-time equivalent (FTE) positions/
1000 acute care beds for antibiotic/infectious disease
lead supervisors, at 2.5 FTE/1000 beds for pharmacists,
and at 0.6 FTE/1000 beds for microbiologists [16]. Most
hospitals in the Netherlands have restricted manpower
for AST and can only focus on a limited number of stew-
ardship activities. Our intervention is free and effective
and can contribute to a simple and successful implemen-
tation of an iv-oral switch program.
Second, our controlled, interrupted time series analysis
design is more robust than (un)controlled before and
after analyses or uncontrolled interrupted time series de-
signs used in most stewardship studies [17]. We were
able to identify a significant difference in intravenous
usage of antibiotics >72 h on the intervention wards
(reduction 19%). However, in the control wards a signifi-
cant effect (reduction 6%) was also found. This effect
could possibly be contributed to the nationwide and local
hospital attention for antimicrobial stewardship during
the time of the study. Nevertheless, our iv-oral switch
intervention was responsible for an additional effect of
13% reduction in iv antibiotic usage >72 h in favor of
the intervention wards.
Our study has some limitations. First, baseline charac-
teristics of the intervention and control groups were not
comparable. The intervention was implemented at in-
ternal medicine wards and the control wards represented
all other hospital wards; the baseline percentage of intra-
venous antibiotic use for >72 h was higher (+0.7%) in the
intervention group. Therefore, the effect of our interven-
tion may not be transferable to all hospital wards. Second,
our intervention was not fully effective, from all antibiotics
eligible for switch, 28% were incorrectly not switched and
due to organizational factors we were not able to imple-
ment the intervention during the weekend. This indicates
that there is still ample room for improvement. Since phy-
sicians were asked to fill in reasons for not switching,
these will be used to improve the educational program.
Third, patients who received solely iv antibiotics could
have been incorrectly excluded, while they may have been
candidates for iv-oral switch therapy. Nowadays, with
modern EHRS, more sophisticated algorithms that are
based on general accepted switch criteria, and that incorp-
orate both clinical, pharmaceutical and laboratory details
could be developed.
Finally, this was a single center study, therefore, results
may not be widely generalizable. However, the iv-oral
switch algorithm was designed based upon commonly
used clinical and laboratory criteria. With the help of an
information technician the implementation in other hos-
pitals with an electronic prescribing system should be
possible.
Conclusion
This study showed the efficacy of an electronic trigger
tool combined with targeted education on iv-oral switch.
The intervention significantly decreased the amount of
intravenously administered antibiotics used for >72 h
by 19%.
This trigger tool enables hospital ASTs to implement a
feasible and effective stand-alone iv-oral switch strategy,
winning them valuable time to address more complicated
issues of antimicrobial prescribing in daily practice.
Additional files
Additional file 1: Appendix 1. Electronic trigger tool algorithm to
identify patients eligible for iv to oral switch. #high dose of a penicillin or
cephalosporin only indicated for severe infection (e.g. endocarditis or
meningitis) or an antibiotic class which is given only if no oral
formulation is available (carbapenem). (JPEG 63 kb)
Additional file 2: Appendix 2. Protocol for iv to oral switch therapy.
(DOCX 17 kb)
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